Feb 9th, 2007, 20:13 | 只看该作者 #323 |
Senior Member
注册日期: Sep 2006
帖子: 699
积分:2
精华:2
声望: 37769
|
OPBL.OB ER: Optionable Reports Record Results for the 2006 Fourth Quarter and Full Year Tuesday February 6, 4:01 pm ET Revenue and Net Income Increase to All Time Highs VALHALLA, N.Y., Feb. 6 /PRNewswire-FirstCall/ -- Optionable, Inc. (OTC Bulletin Board: OPBL - News), a leading provider of natural gas and other energy derivatives brokerage services, announced today record results for its fourth quarter and year ended December 31, 2006. The Company said that revenues increased 310 percent for the fourth quarter and 177 percent for the full year compared to prior-year periods, and net income reached all-time highs, increasing 859 percent for the fourth quarter and 393 percent for the full year compared to prior-year periods. ADVERTISEMENT Revenues for the fourth quarter ended December 31, 2006, were $6.8 million, with net income of $2.5 million, or $0.05 per diluted share, up from $1.7 million in revenue, and net income of $262,769, or $0.01 per diluted share, for the fourth quarter of 2005. Operating margin increased to 58 percent for this year's fourth quarter up from 19 percent for the fourth quarter of 2005. The weighted average number of diluted common shares used in the computations was 53,020,901 and 51,750,647 for the fourth quarter of 2006 and of 2005, respectively. Commenting on the results, Optionable CEO Kevin Cassidy said, "2006 was a benchmark year for us, with the launch of our electronic trading platform, OPEX®, as well as our Analytics service. We're particularly happy with these results as they are due almost entirely to our customers' positive response to the innovative and impeccable service we delivered to them. These results also demonstrate a very healthy and largely untapped market for our derivative brokerage services. "The results for the quarter and the year were driven primarily by our voice-brokerage and open outcry service; however, OPEX, which we launched in July 2006, is beginning to add to our overall revenue mix. We expect that the efficiency of OPEX in executing trades, will cause its contribution to revenue to become a substantial portion of the mix as we progress into 2007 and even 2008, particularly as we begin to open up the market for our services." Cassidy continued, "We intend to build on the success we've enjoyed to date, adding products and services beyond our capabilities in the energy derivative market and Analytics. We intend to look at expanding our relationship with NYMEX, and increase the traction of OPEX. In short, there are a number of strategic opportunities in front of us and we will examine each one thoroughly and carefully in order to continue building Optionable into a force in the derivatives brokerage business. "During the past year we experimented with releasing the number of contracts traded on a monthly basis, but at this point we feel the information is more meaningful when it is part of a quarterly earnings release." Revenues for the year ended December 31, 2006, were $16.1 million, with net income of $6.2 million, or $0.12 per diluted share, up from $5.8 million in revenues with net income of $1.3 million, or $0.02 per diluted share. Operating margin increased to 52 percent for 2006, up from 26 percent for 2005. The weighted average number of diluted common shares used in the computations was 52,559,445 for 2006 and 51,524,732 for 2005. As of December 31, 2006, the Company had cash and cash equivalents of $7.9 million. The Company announced in January 2007 that three of its founding stockholders executed a binding term sheet for an agreement with NYMEX Holdings, Inc. (NYSE: NMX - News; "NYMEX") concerning certain cooperative technology initiatives, the acquisition of a 19 percent stake in Optionable by NYMEX from its three founding stockholders and Optionable's issuance to NYMEX of a warrant which would permit it to increase its ownership in Optionable. The Company also announced in January 2007 that due to its rapid growth, it re-located its headquarters to larger facilities in Westchester County. Webcast of Earnings Conference Call Optionable Inc's management will host a conference call on Tuesday, February 6, 2007, at 5:00 pm Eastern time, to review its 2006 year end results. This call will be broadcast live over the Internet simultaneously and may be accessed at www.optionable.com or www.vcall.com. Web participants are encouraged to go to either website at least 15 minutes prior to the start of the call to register, download, and install any necessary audio software. The online archive will be available shortly after the conclusion of the call and |
|
Feb 10th, 2007, 10:07 | 只看该作者 #326 |
Senior Member
注册日期: Sep 2006
帖子: 699
积分:2
精华:2
声望: 37769
|
标题: 我的稳健 option play (ZT) -------------------------------------------------------------------------------- 我的信仰: 炒option一笔赚头2~10倍并不难, 难的是每月下来都不亏钱. ======================================== When the market went down sharply, it might go down further, or bounce back a lot. Either way, it offers great opportunity for short-term option traders using strangle strategy. I have two examples: 1. CLF May 16 Near 81, bought 300 85C for .55, 50 80C for 2.4 and 180 80P for 1.1. The call/put ratio is roughly 3:2 (considering it has been down a lot to the support level near 80, my position is bullish). May 17, sold 240 85C for 0.9~1.1 and 50 80C for 4.4, leaving all the reminding positioins (calls and puts) free -- I feel no pressure to watch the stock move up or down thereafter. If up, I still have 60 85C for profits, if down, I will rely on 180 80P. May 18, Sold 180 80P for 1.5. As can be seen, this strangle play is with little risk, easy to making 30~200% profits. 2. CME A strangle was placed when CME went down almost $10, near 451 during trading hour of May 17. The dollar amount for calls (460c 450c) and put (440p, 450p) are almost the same. Here is the partial trading execution log: BOT 60 CME MAY06 440.0 PUT Option CNMQS 1.25 0716 + BOT 60 CME MAY06 460.0 CALL Option CNMEL 2.20 0722 + BOT 60 CME MAY06 440.0 PUT Option CNMQS 1.25 0730 + BOT 60 CME MAY06 450.0 PUT Option CNMQR 4.10 0742 + BOT 40 CME MAY06 450.0 CALL Option CNMER 6.30 0753 SLD 5 CME MAY06 440.0 PUT Option CNMQS 3.10 0951 SLD 40 CME MAY06 450.0 PUT Option CNMQR 7.00 0929 + SLD 60 CME MAY06 440.0 PUT Option CNMQS 2.70 0949 + SLD 20 CME MAY06 450.0 CALL Option CNMER 5.70 09:50:11 + SLD 40 CME MAY06 460.0 CALL Option CNMEL 1.90 09:50:32 + BOT 60 CME MAY06 440.0 CALL Option CNMES 6.30 11:47:43 + BOT 80 CME MAY06 440.0 PUT Option CNMQS 4.39875 11:52:40 SLD 60 CME MAY06 440.0 CALL Option CNMES 11.60 1205 + SLD 60 CME MAY06 440.0 PUT Option CNMQS 3.30 12:20:35 SLD 60 CME MAY06 440.0 PUT Option CNMQS 3.00 1221 SLD 10 CME MAY06 450.0 PUT Option CNMQR 7.00 1240 Even though the overall performance is only about 60%, considering it is using a less-risky strategy (strangle) and lots of money can be put into work, it is a great trade. |
|
Feb 10th, 2007, 16:54 | 只看该作者 #328 |
Senior Member
注册日期: Sep 2006
帖子: 699
积分:2
精华:2
声望: 37769
|
有帮助就好. 我是在电脑里存的, 我记得是www.goofiz.com 里的BIOTECH贴的, 你找找看. |
|
Feb 11th, 2007, 23:23 | 只看该作者 #330 |
Senior Member
注册日期: Sep 2006
帖子: 699
积分:2
精华:2
声望: 37769
|
A Universe of Great Stocks By Rik Silverman February 5, 2007 "Prediction is hard, especially about the future." Niels Bohr and Yogi Berra had it right, and their wisdom applies just as well in investing. (Makes you wonder what else the Nobel-winning physicist and Hall of Fame catcher have in common.) Finding the stocks that will power your portfolio into the future can be a daunting task. While growth stocks can offer incredible returns -- see Dell (Nasdaq: DELL) or Qualcomm (Nasdaq: QCOM) -- the duds among this asset class have historically made it one of the worst places for your money. That's too bad, because finding a great growth stock before the broader market does is one of the most rewarding experiences in investing. Growth investing is often more art than science, so there's no surefire way to spot these companies. But some investors have been able to consistently find these businesses and ride their coattails, and I have spotted one of them -- Fool co-founder David Gardner. Here's the five-step process David uses to make his recommendations for Motley Fool Rule Breakers. He asks himself: What is the market cap potential in five years? What is the probability of that happening? How strong is the branding position of the company? How strong are the core values of the company? What does the competition look like (less is more)? This simple framework will help you find great companies with great people with great potential. And if you find enough of those, there's likely to be a big winner among them. Where to start Of course, now you need some companies to put through that five-part test. Allow me to introduce you to our Rule Breakers Universe. The Rule Breakers Universe is a collection of companies that Rule Breakers is watching as we search for the next great growth stocks. The newly re-launched universe brings together companies with dynamic rates of growth, and revolutionary or disruptive forces that are undermining status quo business models. Bookmark the Rule Breakers Universe tag to keep an eye on these companies -- you'll see the group's one-day, 30-day, and one-year performance alongside each stock's CAPS rating. (In the case of some, there's no rating yet -- let us know what you think of these stocks and help them get rated!) CAPS is the Fool's new community stock-rating database that brings together thousands of investors' opinions on thousands of stocks, and it's a treasure trove of information and ideas. The next great growth stock We'll be watching this universe as we continue our search for great growth stocks, and so should you. More than a dozen of these companies have five-star CAPS ratings. Take a look at China Mobile (NYSE: CHL), the leading cell phone and telecom provider in the world's most populous country. Or Quest Diagnostics (NYSE: DGX), making medical tests that help doctors help their patients. A quick scan of the Rule Breakers Universe reveals many more possibilities, including: Company Sector CAPS Rating Medarex (Nasdaq: MEDX) Biotechnology 5 Stars Garmin Electronics 4 Stars Komag Electronics 4 Stars The9 (Nasdaq: NCTY) Online Entertainment 4 Stars Data as of Feb. 1, 2007. Beyond the universe At Rule Breakers, we use the universe as part of our search to bring you two stock recommendations each month, companies we think will be the next great growth investments. Several companies have already made the leap from the universe to become full-fledged recommendations. One is Suntech Power (NYSE: STP), a Chinese manufacturer of photovoltaic cells used to generate solar power; the stock is up more than 25% since it was recommended last year. You can see what else we've found so far -- a group that's beating the market on average by five percentage points -- with a free trial to Rule Breakers. Click here to check out all our past recommendations and analysis, join our discussion boards, read exclusive CEO interviews, and more, all free for 30 days. Predicting the future of investing will never be easy, but finding the companies that will lead the way -- on growth potential, branding, core values, and competitive edge -- is a great place to start. You just need to know which corner of the universe to look in. |
|
Feb 12th, 2007, 10:57 | 只看该作者 #331 |
Senior Member
注册日期: Sep 2006
帖子: 699
积分:2
精华:2
声望: 37769
|
各款UBM的价钱. http://www.ophthalmic.com/ubm.htm Ocular Surgery Workstation The Ocular Surgery Workstation comprises the base system of the Precisionist ThirtyThousand, which uses the computer technology to offer seamless open architecture expandability of the system hardware and software modules. The Workstation utilizes an embedded open architecture computer developed for the Company and controlled by a software system developed by the Company that interfaces with all components of the system. Ultrasound, fluidics (irrigation), aspiration, venting, coagulation and anterior vitrectomy (pneumatic) are all included in the base model. Each component is controlled as a peripheral module within this fully integrated system. Photon Laser System The Photon laser cataract system is designed to be installed as a seamless plug-in upgrade or add-on to the Company's Precisionist Ocular Surgery Workstation. The main elements of the laser system are the Nd:YAG laser module, Photon laser software package and interchangeable disposable hand held fiber optic laser cataract probe. The Photon laser utilizes the on board microprocessor computer of the Workstation to generate short pulse laser energy developed through the LCP to targeted cataract tissue inside the eye, while simultaneously irrigating the eye and aspirating the diseased cataract tissue from the eye. Surgical Instruments and Disposables In addition to the cataract surgery equipment, the Company's surgical systems utilize or will utilize accessory instruments and disposables. These include replacement ultrasound tips, sleeves, tubing sets and fluidics packs, instrument drapes and laser cataract probes. Diagnostic Eye Care Products Glaucoma is described as a partial or total loss of visual field resulting from certain progressive disease or degeneration of the retina, macula or nerve fiber bundle. The cause and mechanism of the glaucoma pathology is not completely understood. Present detection methods focus on the measurement of intraocular pressure in the eye, visual field and observation of the optic nerve head to determine the possibility of pressure being exerted upon the retina, and optic nerve fiber bundle, which can diminish visual field. The Company's Blood Flow Analyzer is a portable automated in office system that presents an affordable method for ocular blood flow testing for the ophthalmic and optometric practitioner. The device is a portable desktop system that utilizes a pneumatic Air Membrane Applanation Probe (AMAP), which can be attached to any model of standard examination slit lamp, which is then placed on the cornea of the patient's eye to measure the intraocular pressure within the eye. The Company markets the Blood Flow Analyzer as a stand-alone model packaged with a custom built computer system. The Blood Flow Analyzer utilizes a single use disposable cover for the Air Membrane Applanation Probe, a corneal probe, which is shipped in sterile packages. Dicon Perimeters: Dicon perimeters consist of the LD 400, the TKS 5000, and software consisting of FieldLink, FieldView and Advanced FieldView. Perimeters are used to determine retinal sensitivity testing the visual pathway. The LD 400FT, or Fast Threshold Autoperimeter, is the successor to the LD 400. The device is an autoperimeter used to measure patient visual fields. Dicon corneal topographers include the CT 200 and the CT 50. Corneal topographers are used to determine the shape and integrity of the cornea, the anterior surface of the eye. Clinical applications for corneal topographers include refractive surgery that eliminates the need for eyeglasses and optometric applications, including contact lens fitting. P55 Pachymetric Analyzeris an ultrasonic pachymeter, which is used for measurement of corneal thickness. The Model P55 is positioned as a standard office pachymeter. The A/B Scan is used by retinal subspecialists to identify foreign bodies in the posterior chamber of the eye and to evaluate the structural integrity of the retina. The P40 biomicroscope creates a high-resolution computer image of the unseen parts of the eye that is a map for the glaucoma surgeon. The Company introduced the P45 UBM Ultrasonic Biomicroscope, which combines the P40 biomicroscope and the P37 A/B Scan Ocular Ultrasound Diagnostic into one instrument. 此帖于 Feb 12th, 2007 11:27 被 chinasmile1 编辑。 |
|
Feb 15th, 2007, 10:23 | 只看该作者 #333 | |
股市阿童木
注册日期: Jul 2004
帖子: 6,014
声望: 4716695
|
引用:
另外真正的底部初学者没有一定的功底很难预测,因为高位和低位、成交量大小等都是相对的。很多看似底部的事后证明仅仅是一次再次下跌之前的调整而已。后面的判断是不是真正的底部的标准已经被验证的时候,不正是市场已经明朗波段和短线投机者入场的时候吗?是不是说还是要等市场明朗才应该入场?而不是尝试去掏底? 新手疑惑,还望有经验的前辈给予解惑,比如如何能提前区分(未明朗之前)真正的底部而不是某一些类似的调整。 |
|
|